Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05732285 · ClinicalTrials.gov registry record · NA

A Pilot Randomized Controlled Trial: CoINTEGRATE

A NA study of Multiple Sclerosis and Mild Cognitive Impairment, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05732285 is a NA study of Multiple Sclerosis and Mild Cognitive Impairment that has completed, run by University of Michigan. The registered enrollment target is 15 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05732285, a NA study of Multiple Sclerosis and Mild Cognitive Impairment, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility of comprehensive multimodal individually tailored Cognitive Behavioral Therapy (CBT), Cognitive Rehabilitation Therapy (CRT), and modifiable lifestyle sessions. The study team hypothesizes that combining evidence-based cognitive and affective therapies with lifestyle modifications is feasible and will improve the community integration (CI) and Quality of life (QoL) in patients with a neurocognitive disorder compared to usual care.

Interventions

  • BEHAVIORAL CBT
  • BEHAVIORAL CRT
  • BEHAVIORAL Modifiable lifestyle factors
  • BEHAVIORAL Usual care Psychoeducation

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-09-01
Est. Completion 2025-10-01
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05732285

The ClinicalTrials.gov registry entry for NCT05732285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which CBT is the first listed.

NCT05732285 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05732285 about?

NCT05732285 is a clinical study titled "A Pilot Randomized Controlled Trial: CoINTEGRATE". The purpose of this study is to examine the feasibility of comprehensive multimodal individually tailored Cognitive Behavioral Therapy (CBT), Cognitive Rehabilitation Therapy (CRT), and modifiable lifestyle sessions. The study team hypothesizes that combining evidence-based cognitive and affective ...

What is the current status of trial NCT05732285?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-09-01. Estimated completion is 2025-10-01.

What conditions does trial NCT05732285 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Mild Cognitive Impairment, Traumatic Brain Injury, Cognitive Dysfunction, Neurocognitive Disorders.

What interventions are being tested in trial NCT05732285?

The interventions under investigation include: CBT (BEHAVIORAL), CRT (BEHAVIORAL), Modifiable lifestyle factors (BEHAVIORAL), Usual care Psychoeducation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05732285?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05732285 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.